Summary:
The NCCIH Natural Product Mid-Phase Clinical Trial Grant supports investigator-initiated research on promising natural products for treating various health conditions. This grant helps bridge the gap between preliminary evidence and large-scale efficacy trials, accelerating the development of safe and effective natural health solutions.
Sponsor:
National Center for Complementary and Integrative Health (NCCIH), part of the National Institutes of Health (NIH)
Eligibility:
- Public or private institutions of higher education, non-profit organizations, and for-profit organizations.
- The proposed clinical trial must focus on a natural product (botanicals, dietary supplements, probiotics) with a strong scientific rationale for further testing.
- The trial must aim to determine optimal dosage, formulation, or patient selection criteria for future efficacy studies.
- Preliminary data demonstrating bioavailability (if applicable) and measurable impact on the product’s mechanism of action is required.
- Applicant must have the expertise and resources to conduct a high-quality clinical trial.
Benefits:
- Funding: Up to $500,000 per year for up to 5 years (subject to available funds and satisfactory progress).
- Support: Access to NCCIH scientific and regulatory expertise, collaboration opportunities, and potential dissemination resources.
- Potential impact: Contribute to the development of evidence-based natural health therapies and improve public health outcomes.
Deadline:
- Standard application due dates: March 4, 2024, October 21, 2024, June 23, 2025, etc.
- AIDS-related application due dates: March 13, 2024, November 13, 2024, etc.
- Check the official grant announcement for specific deadlines and any upcoming changes.
Additional Notes:
- This is a competitive grant program.
- Applications must be submitted through the NIH electronic system (Grants.gov).
- For more information and detailed application instructions, refer to the official grant announcement on the NCCIH website.